First Time Loading...

Horizon Therapeutics PLC
NASDAQ:HZNP

Watchlist Manager
Horizon Therapeutics PLC Logo
Horizon Therapeutics PLC
NASDAQ:HZNP
Watchlist
Price: 116.3 USD Market Closed
Updated: May 7, 2024

Horizon Therapeutics PLC
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Horizon Therapeutics PLC
Cash from Operating Activities Peer Comparison

Comparables:
ALKS
AMRN
PRTA
M
MURA

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Horizon Therapeutics PLC
NASDAQ:HZNP
Cash from Operating Activities
$1B
CAGR 3-Years
49%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Alkermes Plc
NASDAQ:ALKS
Cash from Operating Activities
$401.4m
CAGR 3-Years
69%
CAGR 5-Years
32%
CAGR 10-Years
11%
Amarin Corporation PLC
NASDAQ:AMRN
Cash from Operating Activities
$6.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Prothena Corporation PLC
NASDAQ:PRTA
Cash from Operating Activities
-$133.9m
CAGR 3-Years
-19%
CAGR 5-Years
-36%
CAGR 10-Years
-15%
M
Mural Oncology PLC
NASDAQ:MURA
Cash from Operating Activities
-$194.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Horizon Therapeutics PLC's Cash from Operating Activities?
Cash from Operating Activities
1B USD

Based on the financial report for Jun 30, 2023, Horizon Therapeutics PLC's Cash from Operating Activities amounts to 1B USD.

What is Horizon Therapeutics PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
37%

Over the last year, the Cash from Operating Activities growth was -26%. The average annual Cash from Operating Activities growth rates for Horizon Therapeutics PLC have been 49% over the past three years , 37% over the past five years .